SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry ($BB.TSX) is trending as investors anticipate upcoming earnings, with community members expressing optimism about QNX technology and its role in automotive and IoT sectors. Bullish sentiment is fueled by technical indicators, such as golden crosses and wedge formations, suggesting a potential breakout. Discussions also focus on future revenue and profitability, with some highlighting the company's strategic partnerships and potential for growth.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as traders discuss the potential for a biotech sector rally, fueled by optimism around AI-driven drug discovery and development. Community members are actively trading LABU calls, citing technical indicators and potential market shifts from crypto and big tech into US small caps. Several news articles are circulating highlighting advancements in AI applications within the pharmaceutical and healthcare industries, further contributing to the bullish sentiment.

Anheuser-Busch InBev SA/NV operates as a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies. The company was founded on August 2, 1977 and is headquartered in Leuven, Belgium.

Anheuser-Busch InBev SA/NV - ADR

Anheuser-Busch InBev

Anheuser-Busch InBev (BUD) is trending amid discussions around market share, brand perception, and a recent acquisition of BeatBox Beverages. Community members debate the company's long-term strategy, with some citing concerns around market share and previous marketing decisions, while others point to positive momentum from digital channels and expansion into new beverage categories. Broader market conditions and potential impacts from changing consumer preferences are also being considered.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

The launch of the Bitwise XRP ETF, trading under the ticker TOXR, is driving much of the current conversation around XRP. Community members are debating the potential impact of the new ETF on XRP's price, analyzing technical charts, and discussing entry points. Some are optimistic about institutional adoption and a potential Christmas rally, while others express concerns about trading volume and regulatory hurdles.

Decentraland

Decentraland's MANA is trending as gaming tokens gain momentum, with community members actively discussing potential metaverse news and price predictions. The recent price action and strong volume have reignited interest, with some speculating about a run to previous all-time highs. There is optimism surrounding the broader gaming and metaverse sector, with some comparing MANA's potential to that of other cryptocurrencies that have experienced significant growth after ETF developments.

Immunome, Inc. is a biopharmaceutical company, which engages in the discovery and development of antibody therapeutics products. It also focuses on oncology and infectious disease areas. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Bothell, WA.

Immunome Inc

IMNM is trending as investors digest news of upcoming Phase 3 data and recent business development activities, including acquisitions to bolster their antibody-drug conjugate capabilities. Community discussion revolves around the potential for a squeeze, with some expressing concern over the company's cash runway and others highlighting insider buying. The stock's volatility and upcoming data readouts are key points of interest for traders.

Equinox Gold Corp. is a growth-focused mining company, which engages in the exploration of gold mining properties. It operates through the following segments: Greenstone, Mesquite, Castle Mountain, Los Filos, Aurizona, Fazenda, RDM, Santa Luz, and Corporate. The company was founded by Marc Pais on March 23, 2007, and is headquartered in Vancouver, Canada.

Equinox Gold Corp

Equinox Gold is trending due to the announcement of selling its Brazil operations for over $1 billion, a move aimed at focusing on North American growth and generating significant upfront cash. The community is discussing the potential upside from this strategic shift, especially with the price of gold holding strong, and some are noting large call option purchases signaling bullish sentiment. Some analysts have also raised their price targets, adding to the positive momentum.

Tyson Foods, Inc. engages in the processing of prepared food and other related products. It operates through the following segments: Beef, Pork, Chicken, and Prepared Foods. The Beef segment includes processing live fed cattle and fabricating dressed beef carcasses into primal and sub-primal meat cuts and case-ready products. The Pork segment focuses on live market hogs and fabricating pork carcasses. The Chicken segment is involved in raising and processing live chickens into fresh, frozen, and value-added chicken products, and sales from specialty products. The Prepared Foods segment manufactures and markets food products and offers logistic operations to move products through the supply chain. The company was founded by John W. Tyson in 1935 and is headquartered in Springdale, AR.

Tyson Foods, Inc. - Ordinary Shares - Class A

Tyson Foods, Inc.

Tyson Foods ($TSN) is trending as community members discuss options activity and potential upside, with some citing a cup and handle formation and increased price targets. Recent actionable trade alerts highlight bullish sentiment based on moving averages, while others point to overbought conditions and potential pullbacks. The company's recent earnings report and capacity adjustments in beef processing are also driving conversation.

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals is trending due to a surge in bullish sentiment and strong breakout momentum, with high insider ownership fueling speculation of "smart money" involvement. Community discussions revolve around insider buying, share counts, and the potential for a phase III cancer trial. Some investors express concern about management while others anticipate further gains.

Loopring is a Decentralized Exchange (DEX) built on an Ethereum Layer-2 (L2) solution called zkRollup. It has both Automated Market Maker (AMM)-based and orderbook-based exchanges.   zkRollup is an Ethereum L2 scaling solution that migrates computations off the blockchain. Loopring protocol only uses the underlying Ethereum blockchain as a data layer and a verification layer. As a result, Loopring's throughput is as high as 2,025 trades per second compared to Ethereum’s current throughput of 15 transactions per second. The result is that the cost per trade settlement is as small as $0.00015.  Loopring's performance is sufficient for professional traders and market makers to deploy algorithmic strategies and other automated trading bots. This was not previously possible on any DEX as it was prohibitively slow and expensive. By building on top of Loopring 3.0, orderbook-based DEXs can be commercially viable for the first time. Loopring expects non-custodial exchanges can begin to outcompete and displace many centralized counterparts.

Loopring

Loopring is trending as traders discuss its potential for a short squeeze and speculate on upcoming price movements, with some community members pointing to bullish chart patterns. AI news surrounding $PROMPT and $NVDA may be contributing to the upward momentum. The coin's historical connection to GameStop and current state as a Layer 2 project are also part of the conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Ondas said that Sentry CS has seen rapid growth, with combat-proven deployments across 25 countries, and has achieved fully operational threat mitigation.</li><li>The company expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.</li><li>Last week, Ondas announced a definitive agreement to acquire a controlling interest in 4M Defense, an Israeli smart demining company specializing in advanced demining capabilities.</li></ul>Ondas Holdings Inc. (ONDS) became one of the top trending tickers on Stocktwits and the company’s shares rose 4% in early trading on Tuesday following the announcement that it has entered into a definitive agreement to acquire Sentry CS, an Israel-based company in Cyber-over-RF (CoRF) and Protocol-Manipulation counter-Unmanned Aerial Systems (UAS) technology."The addition of Sentrycs will strengthen our leadership in counter-UAS and solidify Ondas' position as a full-spectrum provider of autonomous defense solutions," said Eric Brock, Chairman and CEO of Ondas Holdings.&nbsp;Ondas expects the transaction to close in November 2025. The terms of the deal were not disclosed.Retail sentiment on Ondas jumped to ‘bullish’ from ‘bearish’ territory compared to a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits.<h2 class="st-heading-2">Sentry CS’ Technology</h2>Ondas said that Sentry CS has seen rapid growth, with combat-proven deployments across 25 countries, and has achieved fully operational threat mitigation."Passive RF detection and tracking are essential to modern layered defense, and Sentrycs brings a proven technology platform already deployed across sensitive airspace, critical infrastructure, and border environments,” Brock said.Brock added that by integrating Sentry CS with Ondas’ Iron Drone Raider system, the company expects to deliver a unified detect-to-defeat solution that addresses the rapidly evolving threat landscape for its defense and homeland security customers worldwide.<h2 class="st-heading-2">Ondas’ Recent Slew Of Acquisitions</h2>Last week, Ondas announced a definitive agreement to acquire a controlling interest in 4M Defense, an Israeli smart demining company specializing in advanced demining capabilities, including robotic systems with terrestrial and subsurface AI-powered intelligence technologies.Ondas had noted that 4M Defense will expand Ondas Autonomous Systems’ addressable market into the large global landmine and UXOs clearance and subsurface intelligence platforms market.The company had also announced the acquisition of a controlling interest in Insight Intelligent Sensors, an Israeli developer of AI-driven electro-optical sensing systems.<a href="https://stocktwits.com/symbol/ONDS">Shares of Ondas</a> have gained over 771% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dennys-620-million-deal-oppenheimer-says-not-expecting-competitive-bidding-process/cL28guSR36a">Denny's $620 Million Deal: Oppenheimer Says Not Expecting ‘Competitive Bidding Process’</a>

In this photo illustration, a person holds a smartphone displaying the logo of Ondas Holdings Inc. 

ONDS Stock Rises Following Acquisition Of Israel-Based Sentry CS

Ondas expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.

Equity

Ondas expects the transaction to close in November 2025, and the terms of the deal have not been disclosed.


Time to fade momentum trade, Jefferies says

Investing.com -- The momentum factor weakened in December, but more downside can be expected in the first quarter, according to a Jefferies strategist.

Shares of Aquestive Therapeutics, Inc. (<a class="mention" data-mention="$AQST" data-symbol-id="AQST" href="https://stocktwits.com/symbol/AQST" target="_blank">$AQST</a>) traded flat early on Thursday, paring pre-market gains, amid a surge in retail chatter that pushed the stock into the top 10 trending tickers on Stocktwits.&nbsp;The company reported positive topline results from its Oral Allergy Syndrome (OAS) challenge study for its Anaphylm Sublingual Film.&nbsp;This study marks the final supportive adult trial in the Anaphylm development program ahead of discussions with the U.S. Food and Drug Administration (FDA).Both the primary and secondary endpoints of the study were successfully met, with no significant differences observed between Anaphylm’s pharmacokinetics (PK) in subjects with and without allergen exposure.&nbsp;The Tmax, or time to maximum plasma concentration, remained at 12 minutes in both groups, while the Cmax, or maximum plasma concentration, was consistent between them.&nbsp;The drug was also found to be safe and well-tolerated, with all adverse events reported as mild or moderate, resolving without medical intervention.On Stocktwits, retail sentiment for AQST surged into the ‘extremely bullish’ zone as of 9:30 am ET, accompanied by a sharp increase in message volume.<stembedurl>https://stocktwits.com/Outrageous/message/589944616</stembedurl><stembedurl>https://stocktwits.com/BioEmerging/message/589945926</stembedurl>A little over a week ago, H.C. Wainwright raised its price target on Aquestive Therapeutics to $10 from $9, maintaining a ‘Buy’ rating.&nbsp;The analyst cited the company’s virtual investor day, which provided insights into its technology platform, product development, and long-term strategy.Last month, Aquestive highlighted its Anaphylm Sublingual Film and AQST-108 Topical Gel during the event, both emerging from the company’s Adrenaverse epinephrine prodrug platform.&nbsp;CEO Daniel Barber expressed optimism about the company’s pipeline, mentioning that they had submitted a pre-NDA meeting request to the FDA for Anaphylm and were on track to report topline data from the OAS study.Looking ahead, the company expects to hold a pre-Investigational New Drug (IND) meeting with the FDA in Q1 2025 and plans to begin a Phase 2 study for AQST-108, targeting alopecia areata, in the second half of 2025, pending FDA alignment.Aquestive’s stock has gained over 160% year-to-date.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/vktx-stock-jumps-after-q3-earnings-beat/cJ218ORR7f">Viking Therapeutics Stock Jumps After Q3 Earnings Beat: Retail Stays Cheerful</a>

Aquestive Therapeutics Pushes Retail Sentiment Into ‘Extremely Bullish’ Zone On OAS Drug Trial Success

This study marks the final supportive adult trial in the Anaphylm development program ahead of discussions with the U.S. FDA.

Current Price	$99.51
Prev Close	$101.48
Open	$101.13
Dividend Yield	N/A
50-Day Moving Average	$94.42
Beta	N/A
Avg. Volume	23,634.89
PE Ratio	N/A

52-Week High	$101.71
52-Week Low	$66.94
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

DWAS
Invesco Dorsey Wright SmallCap Momentum ETF

Feed

News

Sentiment

Fundamentals

Info

Latest DWAS News

DWASInvesco Dorsey Wright SmallCap Momentum ETF